OVERLAND PARK, Kan.--(BUSINESS WIRE)--Dr. Vince Clinical Research (DVCR), a full-service Phase I-II contract research organization (CRO), announced a new solution to conduct renal and hepatic impairment studies. The solution leverages trusted relationships and more effective management of highly regarded specialty sites and subject matter experts to optimize study timelines, ensure efficient recruitment and generate quality data in this highly competitive space.

堪萨斯州奥弗兰德公园（OverlandPark）--（商业新闻短讯）--Dr。Vince Clinical Research（DVCR）是一家全面服务的I-II期合同研究组织（CRO），它宣布了一种新的解决方案来进行肾脏和肝脏损害研究。该解决方案利用受信任的关系以及对备受推崇的专业网站和主题专家的更有效管理，优化学习时间表，确保高效招聘，并在这个竞争激烈的领域生成高质量数据。

By combining DVCR’s full suite of clinical trial services with their sites’ expertise and thorough understanding of the patient populations required for these studies, this end-to-end solution will challenge the current landscape for managing organ impairment studies..

通过将DVCR的全套临床试验服务与他们的网站的专业知识以及对这些研究所需患者群体的透彻理解相结合，这种端到端的解决方案将挑战当前管理器官损伤研究的格局。。

“Renal and hepatic impairment studies present a set of challenges not seen in most other clinical pharmacology trials because there are a limited number of experienced sites with access to the necessary patient populations,” said DVCR CEO and Medical Director Bradley Vince, D.O. “Furthermore, successfully conducting organ impairment trials requires a unique approach with our sites which enables them to deliver results to their maximum potential.”.

DVCR首席执行官兼医学总监布拉德利·文斯（BradleyVince）说：“肾脏和肝脏损害研究提出了一系列挑战，这在大多数其他临床药理学试验中都没有看到，因为有经验的网站数量有限，可以接触到必要的患者群体。”，D.O.“此外，成功进行器官损伤试验需要我们的网站采用独特的方法，使他们能够最大限度地发挥其潜力。”。

DVCR’s trusted relationships with these specialty sites cater to the specific demands of these trials and offer sponsors seamless access for their research,” says Korey Nevitt, DVCR’s Executive Director of Site Partnerships. He continues: “We take a hands-on approach to managing our partner sites for renal and hepatic impairment studies, ensuring streamlined operations and optimal performance in everything from patient enrollment to data management, medical writing and more.”.

DVCR与这些专业网站的信任关系满足了这些试验的具体需求，并为赞助商的研究提供了无缝的访问渠道，”DVCR网站合作执行董事Korey Nevitt说。他继续说：“我们采取实际操作的方法来管理我们的肾脏和肝脏损伤研究合作伙伴网站，确保从患者登记到数据管理、医学写作等各个方面的简化操作和最佳表现。”。

One such site which DVCR has partnered with is Elixia, and their Chief Scientific Officer Harry Alcorn, Pharm.D., who has served as an investigator on over 350 renal and hepatic impairment protocols. “Conducting these specialty population studies while ensuring the safety of the patients and obtaining quality data demands a long-term relationship,” said Alcorn, “You have to make sure that sites are being properly supported and given the tools they need to succeed by a CRO partner with the knowledge and experience required for these studies.

DVCR与之合作的一个这样的网站是Elixia及其首席科学官Harry Alcorn，Pharm.D.，他曾担任350多个肾脏和肝脏损伤方案的研究者。Alcorn说：“在确保患者安全和获得高质量数据的同时进行这些专业人群研究需要长期的关系，你必须确保网站得到适当的支持，并获得CRO合作伙伴所需的工具，这些合作伙伴具有这些研究所需的知识和经验。

Even better if you are working with a CRO that understands the nuances of clinical pharmacology studies with respect to operations, timelines and financial components. This is why we are thrilled to be partnering with Dr. Vince Clinical Research on upcoming renal and hepatic studies.”.

如果你与CRO合作，了解临床药理学研究在运营、时间表和财务组成方面的细微差别，那就更好了。这就是为什么我们很高兴与文斯博士合作进行即将进行的肾脏和肝脏研究的临床研究。”。

Read our interview with Harry Alcorn regarding best practices for conducting renal and hepatic impairment studies.

阅读我们对哈里·奥尔科恩（HarryAlcorn）的采访，了解进行肾脏和肝脏损害研究的最佳实践。

DVCR looks forward to offering this additional service to its current and future biopharmaceutical sponsors to support their NDA submission packages.

DVCR期待着为其当前和未来的生物制药赞助商提供这项额外服务，以支持其NDA提交包。

About Dr. Vince Clinical Research

关于Vince博士的临床研究

Dr. Vince Clinical Research (DVCR) is a world-class full-service CRO (Contract Research Organization) with a custom-built, green-designed headquarters and research complex encompassing three buildings in Overland Park, KS. DVCR’s complex includes a 90-bed clinical pharmacology unit featuring a combination of luxurious and private research suites and a GMP-compliant pharmacy with positive and negative pressure compounding rooms.

文斯临床研究（DVCR）博士是一家世界一流的全方位服务CRO（合同研究组织），拥有定制的绿色设计总部和研究综合楼，涵盖堪萨斯州奥弗兰德公园的三栋建筑。DVCR的综合设施包括一个拥有90张床位的临床药理学单元，该单元结合了豪华和私人研究套房，以及一个符合GMP的药房，该药房具有正压和负压配制室。

DVCR specializes in conducting clinical trials for both healthy normal volunteers and patient populations in a wide variety of early phase trials. By leveraging both technology and one of the country’s most experienced leadership teams, DVCR provides Smarter, Faster Data to their biopharmaceutical clients..

DVCR专门为健康正常志愿者和患者人群进行各种早期试验。通过利用技术和国内最有经验的领导团队之一，DVCR为其生物制药客户提供了更智能、更快的数据。。

For more information, go to sponsors.drvince.com. Connect with Dr. Vince Clinical Research on LinkedIn and YouTube.

有关更多信息，请访问sponsors.drvince.com。在LinkedIn和YouTube上与Vince博士临床研究联系。

About Elixia

关于艾莉霞

Elixia is an innovator in patient recruitment and clinical trials management and analysis for three targeted therapeutic areas: Cardiology/Nephrology, Behavioral Health and Infectious Disease. Our break-through approach helps drug developers not only meet milestones with record speed and agility, but enroll and retain the right patients, trial after trial.

Elixia是三个靶向治疗领域的患者招募和临床试验管理和分析的革新者：心脏病学/肾脏病，行为健康和传染病。我们的突破性方法不仅可以帮助药物开发人员以创纪录的速度和灵活性达到里程碑，而且可以在一次又一次的试验中招募和留住正确的患者。

We eliminate traditional trial bottlenecks with a singular combination of specialized clinical expertise and an agile operating model with reproducible processes to deliver start-up and enrollment at uncommonly remarkable speed. Our team of seasoned industry leaders creates a strategy for success from early phase through commercialization, across a sponsor’s entire pipeline.

我们通过专门的临床专业知识和灵活的操作模型以及可重复的流程来消除传统的试验瓶颈，以非凡的速度启动和注册。我们经验丰富的行业领导者团队在赞助商的整个渠道中制定了从早期阶段到商业化的成功战略。

Partnering with Elixia, you get access to top leaders across different sectors of healthcare to drive value in clinical trials and forge better patient outcomes..

与Elixia合作，您可以接触到医疗保健不同领域的顶级领导者，以推动临床试验的价值，并创造更好的患者结果。。